Search results for: physical function

Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Susan Bernstein | April 2, 2014

Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

Global Perspectives on Managing Rheumatoid Arthritis Addressed at the 2013 ACR/ARHP Annual Meeting

Susan Bernstein | April 2, 2014

Poverty, poor access to healthcare, cultural myths present challenges for rheumatologists caring for patients with RA in developing economic regions

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | January 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review

Mary Beth Nierengarten | December 1, 2013

Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology

What Diet to Recommend to Patients with Rheumatoid Arthritis?

Vanessa Caceres | November 1, 2013

With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

EULAR 2013: Researchers Expand Targets for PsA, OA Therapy

Thomas R. Collins | September 1, 2013

Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis

RA Treatment Options Expanded with New Infusible TNF Inhibitor

Richard Quinn | August 21, 2013

FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

Deborah L. Parks, MD | June 1, 2013

Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

ACR/ARHP Annual Meeting 2012: Physicians Search for Ways to Improve Clinical Outcomes for Total Knee Replacements (TKR)

Staff | March 1, 2013

Widely variable results for people post-TKR procedures have prompted doctors to develop a standardized approach to rehabilitation care